USPTO has confirmed REVO patents have been assigned to Eyetalk365. Let me repeat:REVO concluded an exclusive license AND patent assignment The USPTO was told of the assignment, but REVO shareholders were told only of the exclusive license. Eyetalk365 lawyers filed the assignment with USPTO and REVO filed details of the exclusive license with the SEC. Details of the assignment can be found by following this link to the USPTO. http://assignment.uspto.gov/#/assignment?id=36386-715&q=7193644 The facts are set out there, for all to see. Simple.